ArticleMolecular neurobiology2011

Can the chronic administration of the combination of buprenorphine and naloxone block dopaminergic activity causing anti-reward and relapse potential?

Kenneth Blum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.